Malmö Centre for Thrombosis and Haemostasis, Skåne University Hospital, Malmö, Sweden.
Haemophilia. 2011 Mar;17(2):304-11. doi: 10.1111/j.1365-2516.2010.02423.x. Epub 2010 Dec 10.
Severe haemophilia and reduced bone density can negatively influence perception of patient's health-related quality of life (HRQoL), especially considering future aspects, the risk of losing independence or pain suffering. The aim of this study was to assess levels of HRQoL in severe haemophilia patients and to compare HRQoL to those of the general population as well as to determine whether reduced bone density is correlated to the perceived HRQoL. Patients were divided into two groups based on timing of being treated with prophylaxis: Group A (started prophylaxis at age of ≤ 3 years; n = 22); Group B (at age of >3 years; n = 15). The bone mineral density (BMD g cm(-2)) of different measured sites was measured by dual energy X-ray absorptiometry (DXA). HRQoL was assessed using SF-36 questionnaire. Group A have mean BMD T-score >-1.0 (i.e. normal score) at all measured sites, and have almost similar scores in the SF-36 domains compared with the reference population. Group B have mean BMD T-score <-1.0 at hip region, and >-1.0 at lumbar spine and total body, and their scores in the SF-36 domains were lower compared with the reference population. Moreover, significant correlations were found between BMD at femoral neck and total body with physical domains. With adequate long-term prophylaxis since early childhood, adult patients with haemophilia report a comparable BMD and HRQoL to the Swedish reference population. Reduced BMD in group B correlated with impaired physical health, which underscores the importance of early onset of adequate prophylactic treatment.
严重血友病和骨密度降低会对患者的健康相关生活质量(HRQoL)产生负面影响,尤其是考虑到未来的方面,如失去独立性或疼痛的风险。本研究的目的是评估严重血友病患者的 HRQoL 水平,并将其与普通人群进行比较,以及确定骨密度降低是否与感知的 HRQoL 相关。根据开始预防治疗的时间,患者被分为两组:A 组(≤3 岁开始预防治疗;n=22);B 组(>3 岁开始预防治疗;n=15)。使用双能 X 射线吸收法(DXA)测量不同测量部位的骨矿物质密度(BMD g cm(-2))。使用 SF-36 问卷评估 HRQoL。A 组在所有测量部位的平均 BMD T 评分均>-1.0(即正常评分),且在 SF-36 各领域的评分与参考人群几乎相似。B 组在髋部的平均 BMD T 评分<-1.0,在腰椎和全身的平均 BMD T 评分>-1.0,且在 SF-36 各领域的评分均低于参考人群。此外,在股骨颈和全身的 BMD 与生理领域之间发现了显著的相关性。自儿童早期开始进行适当的长期预防治疗后,成年血友病患者报告的 BMD 和 HRQoL 与瑞典参考人群相当。B 组的 BMD 降低与身体功能受损相关,这强调了早期开始适当预防治疗的重要性。